688 related articles for article (PubMed ID: 12679629)
21. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
23. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.
Kim SH; Choi D; Lim JH; Lee WJ; Jang HJ; Lim HK; Lee SJ; Cho JM; Kim SK; Kim GC
Korean J Radiol; 2002; 3(2):87-97. PubMed ID: 12087198
[TBL] [Abstract][Full Text] [Related]
24. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
[TBL] [Abstract][Full Text] [Related]
26. Specificity of SPIO particles for characterization of liver hemangiomas using MRI.
Montet X; Lazeyras F; Howarth N; Mentha G; Rubbia-Brandt L; Becker CD; Vallee JP; Terrier F
Abdom Imaging; 2004; 29(1):60-70. PubMed ID: 15160755
[TBL] [Abstract][Full Text] [Related]
27. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
[TBL] [Abstract][Full Text] [Related]
28. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
[TBL] [Abstract][Full Text] [Related]
30. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences.
Precetti-Morel S; Bellin MF; Ghebontni L; Zaïm S; Opolon P; Poynard T; Mathurin P; Cluzel P
Eur Radiol; 1999; 9(8):1535-42. PubMed ID: 10525860
[TBL] [Abstract][Full Text] [Related]
31. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
33. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
[TBL] [Abstract][Full Text] [Related]
34. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging.
Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK
Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047
[TBL] [Abstract][Full Text] [Related]
35. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
Mergo PJ; Helmberger T; Nicolas AI; Ros PR
AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
[TBL] [Abstract][Full Text] [Related]
36. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
[TBL] [Abstract][Full Text] [Related]
37. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.
Kanematsu M; Itoh K; Matsuo M; Maetani Y; Ametani F; Kondo H; Kato H; Hoshi H
J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831
[TBL] [Abstract][Full Text] [Related]
38. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
[TBL] [Abstract][Full Text] [Related]
40. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
